Insiders who reported open-market trades in the last 12 months at the companies David M. Berman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Bahija Jallal - $371K in IMCR purchases and sales in the last 12 months
Leger Tina Amber St - $32K in IMCR purchases and sales in the last 12 months
John Goll - $23K in IMCR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
David M. Berman is a corporate insider, tracked as HEAD OF R&D of Immunocore Holdings plc (IMCR). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did David M. Berman last file a Form 4?
The most recent primary Form 4 on record is dated 19 February 2026, one of 6 filings going back to 2025.
Has David M. Berman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 12 open-market sales ($8.74M) across all tracked filings.
David M. Berman is HEAD OF R&D of Immunocore Holdings plc (IMCR). 6 SEC Form 4 filings on record going back to 2025, most recently on 19 February 2026. Most recent open-market trade: sold $193K of IMCR on 19 February 2026. Lifetime open-market sales: $8.74M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by David M. Berman.
InsiderAlpha's records for David M. Berman go back to 2025: 6 primary Form 4 filings, an average of 3.0 per year. 12 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
